⌘K

Home/Filings/3/0001474506-24-000225

3//SEC Filing

KNIGHT THERAPEUTICS INTERNATIONAL SA 3

Accession 0001474506-24-000225

CIK 0001562733other

View on SEC.gov Company Profile

Filed

Oct 21, 8:00 PM ET

Accepted

Oct 22, 8:30 PM ET

Size

6.1 KB

Accession

0001474506-24-000225

Insider Transaction Report

Form 3

Period: 2024-10-22

Synergy CHC Corp.SNYR

Knight Therapeutics (Barbados) Inc.

10% Owner

Holdings

Common Stock, par value $0.00001 per share
(indirect: Held through Knight Therapeutics International SA, a subsidiary of Knight Therapeutics Inc.)
1,482,844

Knight Therapeutics Inc

10% Owner

Holdings

Common Stock, par value $0.00001 per share
(indirect: Held through Knight Therapeutics International SA, a subsidiary of Knight Therapeutics Inc.)
1,482,844

Documents

1 file

3
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

Synergy CHC Corp.

CIK 0001562733

Entity typeother

IncorporatedUruguay

Related Parties

1

filerCIK 0001632373

Filing Metadata

Form type: 3
Filed: Oct 21, 8:00 PM ET
Accepted: Oct 22, 8:30 PM ET
Size: 6.1 KB

View on SEC.gov